STRATEGIC RESEARCH PROGRAMMES
Apr 07, 2016
STRA
TEG
IC R
ESEA
RCH
PRO
GRA
MM
ES
BACKGROUND
SingHealth Investigational Medicine Unit (IMU) is an early phase clinical research unit, which supports the research of commercial partners and investigators. The unit is located at Block 7, Level 7 of Singapore General Hospital (SGH) and provides services to facilitate:
KEY OBJECTIVES
De�ning the future of medicine through the conduct of early phase clinical research
Translating innovations into improved patient care
Educating and training researchers in early phase clinical trial research ethics and methodology
Developing thought leadership through research innovations
Proof of concept, '�rst-in-man' or early stages of clinical development of investigational drugs, vaccines and devices
Identi�cation and validation of novel disease biomarkers
PET, CT and MRI facilities
Nuclear medicine
Investigational and chemotherapy pharmacy services
CAP-certi�ed pathology laboratories
We have ready access to various research services, including:
We champion medical research practice and methodology to train doctors, pharmacists, nurses, coordinators and technologists in clinical trial management.
Pharmacokinetics and pharmacodynamics studies
Healthy volunteer and patient trials
CORE STRENGTHS
We specialise in early phase clinical research. Our projects are supported by a team of dedicated and well-trained Clinical Research Coordinators, Clinical Research Nurses and Resident Physicians. The unit specialises in studying diseases that impact patients in Asia, including:
CORE SERVICES
Case Report Form (CRF) design
Specimen collection, handling and processing
Coordination with external central laboratories
Project management of trials
Conducting trials that adhere to Singapore-Good Clinical Practice, supported by a robust healthy volunteer database
FACILITIES
Thirty beds
Two consultation rooms
Dedicated subject recruitment and screening rooms
Two-bed chronobiology suite, managed by Duke-NUS Graduate Medical School Singapore
24/7 CCTV
Storage space for IP
Internal Quality Assurance (QA) system
Clinical pharmacology and pharmacogenetic testing
Sample processing room
2-8oC, -30oC and -80oC refrigerators with 24/7 electronic temperature logs linked to a central alarm system
Wireless, real-time ECG/telemetry
Temperature-controlled centrifuges
HAEMATOLOGY
GASTROENTEROLOGY
EMERGING INFECTIOUS DISEASE
ONCOLOGY
CARDIOLOGY
DIRECTOR’S BIO
Ms Sue Tee, Director, Administration & Operations, Investigational Medicine Unit, SingHealth.
In addition to her role in Administration and Operations at Investigational Medicine Unit, SingHealth, Sue holds the Director, Clinical Trials Development role in SingHealth. Her extensive knowledge of the clinical trials scene enables her to assist in collaborations among multi-sites. In this capacity, she serves as a liaison between the biopharmaceutical companies and SingHealth institutions.
The content is correct at the time of printing.©2015 SingHealth O�ce of Research. All rights reserved.
SingHealth Investigational Medicine Unit (IMU)
Singapore General HospitalBlock 7, Level 7Outram RoadSingapore 169608
Tel: (+65) 6323 7533Fax: (+65) 6323 3971Email: [email protected]
DIRECTOR’S BIO
Assoc. Prof Darren Wan-Teck Lim, Director of Investigational Medicine Unit, SingHealth and Senior Consultant, Division of Medical Oncology, National Cancer Centre Singapore (NCCS).
Assoc. Prof Lim is also co-group leader at the NCCS-MPI-IMCB laboratory at the Institute of Molecular and Cell Biology (IMCB) Singapore. He is Associate Professor at Duke-NUS Graduate Medical School Singapore and adjunct clinical tutor at the Yong Loo Lin School of Medicine, National University of Singapore. His clinical interests are in lung, thyroid, and head and neck cancers. His research interests are in early phase clinical trials with developmental biological correlates.